arrow
S

Sara Valpione

University of Manchester
H指数:34
被引数:4,297

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Treatment strategies with electrochemotherapy for limb in-transit melanoma: real-world outcomes from a European, retrospective, cohort study” [Europ J Surg Oncol 51 (2025) 108740]

勘误:“Treatment strategies with electrochemotherapy for limb in-transit melanoma: real-world outcomes from a European, retrospective, cohort study” [Europ J Surg Oncol 51 (2025) 108740]

2025-11-040
PRE
Are we closing the gender gap in academic oncology? An observational study of gender disparities in participant engagement at the ASCO 2024 annual meeting

我们正在弥合学术肿瘤学中的性别差距吗?一项关于ASCO 2024年会上参与者参与度中性别差异的观察性研究

2025-09-090
OAAI
Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma*

非甾体抗炎药在EORTC 1325/KEYNOTE-054 pembrolizumab与安慰剂在切除的高风险III期黑色素瘤中的预后和预测价值 *

2024-04-010
PRE
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial

尼洛替尼治疗试剂盒驱动的晚期黑色素瘤: II期单臂NICAM试验的结果

2024-03-012
OAAI
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

免疫检查点阻断治疗的晚期黑色素瘤的纵向肠道微生物组变化

2024-02-1617
OAAI
Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

二甲双胍在欧洲癌症研究与治疗组织中的预后和预测价值1325/KEYNOTE-054 pembrolizumab与安慰剂在切除的高风险III期黑色素瘤中的III期试验

2023-08-018
PRE
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma
2023-05-033
OA
Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

pembrolizumab与安慰剂在EORTC 1325/KEYNOTE-054 III期临床试验中 β 受体阻滞剂在切除的高风险III期黑色素瘤中的预后和预测价值

2022-04-0122
OA
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

跨队列肠道菌群与晚期黑色素瘤免疫检查点抑制剂反应的关联

2022-02-28200
OAAI